CD8A and neoplasm: Building on this concept, a pivotal study has shed light on this approach by delivering antibiotics encapsulated in liposomes to target intra-tumor bacteria, eliciting an anti-tumor CD8+ T cell response activated by microbial-derived neoantigens [36].